Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer
Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer
isPeerReviewed
abstract
<p>Patient-derived organoids ( ...... metastatic RAS-mutant CRC.</p>
@en
authorList
type
label
Drug-repurposing screen on pat ...... ty in KRAS-mutant colon cancer
category
electronicVersions
externalOrganisations
journalAssociation
journalNumber
keywordGroups
language
managingOrganisationalUnit
openAccessPermission
organisationalUnits
publicationStatuses
submissionYear
totalScopusCitations
visibility
Publiek - Geen beperking
@nl
workflow
Validated
@en
author
datePublished
2023-04-25